Floatz logo

PROPRANOLOL

Aphasia, Primary Progressive

University of Missouri-ColumbiaSmall moleculeEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Aphasia, Primary Progressive cohort.

Asset / SponsorPhaseRating
FLORTAUCIPIR
Mayo Clinic
Phase 4BBB
Rotigotine
I.R.C.C.S. Fondazione Santa Lucia
Phase 2B
Nabilone
Simon Ducharme, MD
Phase 2CCC
FLORTAUCIPIR
Mayo Clinic
Phase 1CC
PITTSBURGH COMPOUND B UNLABELLED
Mayo Clinic
Phase 1CC

View all 9 →

Same molecule, other indications

PROPRANOLOL is also rated in:

migraine disorderDormant
BBB
Indicative ·
74 / 100
View asset →
esophageal varicesDormant
BBB
Indicative ·
74 / 100
View asset →
esophageal varices with bleedingDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →